Biogen Inc. ? will present new data from its felzartamab clinical development programs at Kidney Week 2025, the American Society of Nephrology's (ASN) annual meeting, taking place November 5-9 in ...
Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding ...
Pilatus Biosciences, a biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, today announced the Company will present new preclinical ...
Early broadly neutralising antibody responses against the E1E2 glycoprotein seem to be important for preventing persistence ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding ...
The increasing knowledge of barrier tissue-resident memory macrophages and trained innate immunity (TII) will help develop both nontarget-specific and target-specific TII-based vaccine strategies.
WENTZVILLE, Mo. (KSDK) - A 12-year-old Missouri girl with cerebral palsy hopes stem cell transfusions will help her walk – but the treatment isn’t cheap, so she’s selling lemonade to ease the cost on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback